Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Rong Zhou. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Rong Zhou har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:AMPH / Amphastar Pharmaceuticals, Inc. | SENIOR EVP, PRODUCTION CENTER | 137 497 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Rong Zhou. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp AMPH / Amphastar Pharmaceuticals, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i AMPH / Amphastar Pharmaceuticals, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel AMPH / Amphastar Pharmaceuticals, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i AMPH / Amphastar Pharmaceuticals, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Rong Zhou som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Srock |
F - Taxes | −1 967 | 137 497 | −1,41 | 27,69 | −54 466 | 3 807 292 | |
2025-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 222 | 139 464 | −0,87 | 26,66 | −32 579 | 3 718 110 | |
2025-03-12 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Srock |
A - Award | 24 692 | 140 686 | 21,29 | ||||
2025-03-10 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 354 | 115 994 | −1,15 | 28,32 | −38 345 | 3 284 950 | |
2025-03-06 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 121 | 117 348 | −0,95 | 27,62 | −30 962 | 3 241 152 | |
2024-12-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −8 000 | 118 469 | −6,33 | 45,23 | −361 840 | 5 358 353 | |
2024-12-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 8 000 | 126 469 | 6,75 | 11,33 | 90 640 | 1 432 894 | |
2024-12-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −7 000 | 118 469 | −5,58 | 44,42 | −310 975 | 5 262 985 | |
2024-12-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 7 000 | 125 469 | 5,91 | 11,33 | 79 310 | 1 421 564 | |
2024-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −6 893 | 118 388 | −5,50 | 48,88 | −336 930 | 5 786 805 | |
2024-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 6 893 | 125 281 | 5,82 | 14,95 | 103 050 | 1 872 951 | |
2024-09-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Srock |
S - Sale | −3 000 | 118 388 | −2,47 | 48,26 | −144 784 | 5 713 582 | |
2024-09-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Srock |
M - Exercise | 3 000 | 121 388 | 2,53 | 14,95 | 44 850 | 1 814 751 | |
2024-08-27 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Srock |
S - Sale | −4 000 | 118 388 | −3,27 | 48,35 | −193 400 | 5 724 060 | |
2024-08-27 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Srock |
M - Exercise | 4 000 | 122 388 | 3,38 | 14,95 | 59 800 | 1 829 701 | |
2024-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 961 | 118 016 | −1,63 | 43,05 | −84 421 | 5 080 589 | |
2024-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Srock |
F - Taxes | −2 355 | 119 977 | −1,93 | 43,05 | −101 383 | 5 165 010 | |
2024-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Srock |
F - Taxes | −1 219 | 122 332 | −0,99 | 43,05 | −52 478 | 5 266 393 | |
2024-03-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Srock |
F - Taxes | −1 390 | 123 551 | −1,11 | 46,31 | −64 371 | 5 721 647 | |
2024-03-06 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Srock |
A - Award | 12 521 | 124 941 | 11,14 | ||||
2023-12-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −3 514 | 112 420 | −3,03 | 59,58 | −209 364 | 6 697 984 | |
2023-12-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 3 514 | 115 934 | 3,13 | 16,19 | 56 892 | 1 876 971 | |
2023-12-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −4 316 | 112 420 | −3,70 | 58,58 | −252 831 | 6 585 564 | |
2023-12-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 4 316 | 116 736 | 3,84 | 14,40 | 62 150 | 1 680 998 | |
2023-06-21 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 9 651 | 112 341 | 9,40 | 11,33 | 109 346 | 1 272 824 | |
2023-06-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 1 171 | 102 690 | 1,15 | 16,19 | 18 958 | 1 662 551 | |
2023-06-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 4 631 | 101 519 | 4,78 | 14,95 | 69 233 | 1 517 709 | |
2023-06-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −5 000 | 96 888 | −4,91 | 51,79 | −258 946 | 5 017 762 | |
2023-06-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 13 575 | 101 888 | 15,37 | 14,40 | 195 480 | 1 467 187 | |
2023-06-14 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −5 000 | 88 313 | −5,36 | 48,24 | −241 200 | 4 260 219 | |
2023-06-14 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 5 000 | 93 313 | 5,66 | 14,40 | 72 000 | 1 343 707 | |
2023-05-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −10 000 | 87 598 | −10,25 | 44,20 | −442 050 | 3 872 270 | |
2023-05-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 000 | 97 598 | 11,42 | 14,40 | 144 000 | 1 405 411 | |
2023-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 901 | 87 598 | −2,12 | 36,29 | −68 987 | 3 178 931 | |
2023-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 283 | 89 499 | −2,49 | 37,60 | −85 841 | 3 365 162 | |
2023-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 057 | 91 782 | −2,19 | 36,84 | −75 780 | 3 381 249 | |
2023-03-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 15 129 | 93 839 | 19,22 | ||||
2022-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 447 | 77 583 | −3,06 | 34,18 | −83 638 | 2 651 787 | |
2022-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 283 | 80 030 | −2,77 | 34,22 | −78 124 | 2 738 627 | |
2022-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 31 516 | 31 516 | |||||
2022-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 652 | 82 313 | −1,97 | 34,74 | −57 390 | 2 859 554 | |
2022-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 13 658 | 83 965 | 19,43 | ||||
2022-03-01 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −7 000 | 0 | −100,00 | ||||
2022-03-01 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −13 246 | 70 307 | −15,85 | 28,77 | −381 087 | 2 022 732 |
2022-03-01 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 7 000 | 83 553 | 9,14 | 10,93 | 76 510 | 913 234 | |
2022-02-09 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −7 000 | 7 000 | −50,00 | ||||
2022-02-09 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −7 000 | 76 553 | −8,38 | 26,77 | −187 390 | 2 049 324 |
2022-02-09 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 7 000 | 83 553 | 9,14 | 10,93 | 76 510 | 913 234 | |
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −14 000 | 14 000 | −50,00 | ||||
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 251 | 76 553 | −11,81 | 25,77 | −264 156 | 1 972 679 |
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 677 | 86 804 | −10,95 | 24,96 | −266 528 | 2 166 871 |
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 14 000 | 97 481 | 16,77 | 10,93 | 153 020 | 1 065 467 | |
2021-11-12 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −7 813 | 0 | −100,00 | ||||
2021-11-12 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −7 813 | 83 121 | −8,59 | 21,67 | −169 308 | 1 801 232 |
2021-11-12 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 7 813 | 90 934 | 9,40 | 10,48 | 81 880 | 952 988 | |
2021-08-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −6 000 | 7 813 | −43,44 | ||||
2021-08-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −9 123 | 83 121 | −9,89 | 21,24 | −193 734 | 1 765 141 |
2021-08-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 6 000 | 92 244 | 6,96 | 10,48 | 62 880 | 966 717 | |
2021-07-27 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −6 000 | 13 813 | −30,28 | ||||
2021-07-27 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −6 000 | 86 244 | −6,50 | 20,87 | −125 220 | 1 799 912 |
2021-07-27 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 6 000 | 92 244 | 6,96 | 10,48 | 62 880 | 966 717 | |
2021-07-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −5 187 | 19 813 | −20,75 | ||||
2021-07-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −5 187 | 86 244 | −5,67 | 20,57 | −106 697 | 1 774 039 |
2021-07-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 5 187 | 91 431 | 6,01 | 10,48 | 54 360 | 958 197 | |
2021-06-10 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −4 732 | 86 244 | −5,20 | 19,58 | −92 653 | 1 688 658 | |
2021-06-10 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −8 180 | 0 | −100,00 | ||||
2021-06-10 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −8 180 | 90 976 | −8,25 | 19,34 | −158 177 | 1 759 203 | |
2021-06-10 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 8 180 | 99 156 | 8,99 | 14,23 | 116 401 | 1 410 990 | |
2021-05-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −11 120 | 8 180 | −57,62 | ||||
2021-05-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −17 419 | 89 966 | −16,22 | 19,72 | −343 464 | 1 773 932 | |
2021-05-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 11 120 | 107 385 | 11,55 | 14,23 | 158 238 | 1 528 089 | |
2021-05-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −700 | 19 300 | −3,50 | ||||
2021-05-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −700 | 96 265 | −0,72 | 19,58 | −13 706 | 1 884 869 | |
2021-05-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 700 | 96 965 | 0,73 | 14,23 | 9 961 | 1 379 812 | |
2021-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 51 621 | 51 621 | |||||
2021-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 21 984 | 96 265 | 29,60 | ||||
2021-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −3 303 | 74 281 | −4,26 | 18,44 | −60 907 | 1 369 742 | |
2021-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 652 | 77 584 | −2,08 | 19,15 | −31 636 | 1 485 734 | |
2020-06-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −8 918 | 0 | −100,00 | ||||
2020-06-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −9 806 | 79 236 | −11,01 | 19,19 | −188 177 | 1 520 539 | |
2020-06-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 8 918 | 89 042 | 11,13 | 11,41 | 101 754 | 1 015 969 | |
2020-06-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −11 082 | 8 918 | −55,41 | ||||
2020-06-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −13 163 | 80 124 | −14,11 | 18,82 | −247 678 | 1 507 629 | |
2020-06-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 11 082 | 93 287 | 13,48 | 11,41 | 126 446 | 1 064 405 | |
2020-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −992 | 80 891 | −1,21 | 14,50 | −14 384 | 1 172 920 | |
2020-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 61 822 | 61 822 | |||||
2020-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 26 400 | 81 883 | 47,58 | ||||
2020-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 020 | 55 483 | −1,81 | 13,03 | −13 291 | 722 943 | |
2020-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 653 | 56 503 | −2,84 | 14,19 | −23 456 | 801 778 | |
2019-06-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −204 | 58 156 | −0,35 | 19,82 | −4 043 | 1 152 652 | |
2019-05-07 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −9 600 | 0 | −100,00 | ||||
2019-05-07 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −9 600 | 57 107 | −14,39 | 22,76 | −218 496 | 1 299 755 |
2019-05-07 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 9 600 | 66 707 | 16,81 | 20,26 | 194 496 | 1 351 484 | |
2019-03-28 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −814 | 57 107 | −1,41 | 20,54 | −16 720 | 1 172 978 | |
2019-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 510 | 57 921 | −2,54 | 20,23 | −30 547 | 1 171 742 | |
2019-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 553 | 59 431 | −2,55 | 20,23 | −31 417 | 1 202 289 | |
2019-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 22 541 | 22 541 | |||||
2019-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 179 | 60 984 | −1,90 | 20,23 | −23 851 | 1 233 706 | |
2019-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 10 133 | 62 163 | 19,48 | ||||
2019-03-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −3 200 | 6 400 | −33,33 | ||||
2019-03-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −3 200 | 52 030 | −5,79 | 25,00 | −80 000 | 1 300 750 |
2019-03-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 3 200 | 55 230 | 6,15 | 20,26 | 64 832 | 1 118 960 | |
2019-03-04 |
|
4/A | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −3 200 | 9 600 | −25,00 | ||||
2019-02-07 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −3 200 | 12 800 | −20,00 | ||||
2019-02-07 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −4 289 | 52 030 | −7,62 | 23,00 | −98 647 | 1 196 690 |
2019-02-07 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 3 200 | 56 319 | 6,02 | 20,26 | 64 832 | 1 141 023 | |
2018-12-06 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −1 089 | 53 119 | −2,01 | 22,00 | −23 958 | 1 168 618 |
2018-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −1 089 | 53 303 | −2,00 | 21,00 | −22 869 | 1 119 363 |
2018-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −1 084 | 54 392 | −1,95 | 20,00 | −21 680 | 1 087 840 |
2018-06-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −134 | 55 476 | −0,24 | 16,88 | −2 262 | 936 435 | |
2018-03-28 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −535 | 54 434 | −0,97 | 18,61 | −9 956 | 1 013 017 | |
2018-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −969 | 54 969 | −1,73 | 19,91 | −19 293 | 1 094 433 | |
2018-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 128 | 55 938 | −1,98 | 19,91 | −22 458 | 1 113 726 | |
2018-03-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 20 827 | 20 827 | |||||
2018-03-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 8 969 | 57 066 | 18,65 | ||||
2017-06-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −146 | 48 096 | −0,30 | 16,18 | −2 362 | 778 193 | |
2017-03-28 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −568 | 46 972 | −1,19 | 13,76 | −7 816 | 646 335 | |
2017-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 248 | 47 540 | −2,56 | 13,75 | −17 160 | 653 675 | |
2017-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 29 424 | 29 424 | |||||
2017-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 11 797 | 48 788 | 31,89 | ||||
2016-12-07 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −61 | 36 991 | −0,16 | 20,70 | −1 262 | 765 547 |
2016-06-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −146 | 36 991 | −0,39 | 15,76 | −2 301 | 582 978 | |
2016-06-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −1 551 | 37 137 | −4,01 | 15,85 | −24 584 | 588 633 | |
2016-03-29 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −568 | 37 137 | −1,51 | 11,96 | −6 793 | 444 159 | |
2016-03-21 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 34 438 | 34 438 | |||||
2016-03-21 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 11 473 | 37 705 | 43,74 | ||||
2015-12-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −772 | 25 460 | −2,94 | 14,29 | −11 032 | 363 826 | |
2015-06-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −1 000 | 26 232 | −3,67 | 16,48 | −16 480 | 432 303 | |
2015-06-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 4 685 | 4 685 | |||||
2015-06-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 1 544 | 27 232 | 6,01 | ||||
2015-06-17 | 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
156 044 | ||||||||
2015-06-17 | 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
230 024 | ||||||||
2015-06-17 | 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
135 356 | ||||||||
2015-06-17 | 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
156 044 | ||||||||
2015-06-17 | 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
230 024 | ||||||||
2015-06-17 | 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
135 356 |